1. In memorium: Jorgen Rygaard (1934-2016) Father of patient derived mouse models of cancer and modern cancer research.
2. The revival of patient-derived mouse models of cancer: way back to the future
3. Patient-derived xenograft models for human cancer, The Freiburg experience
4. From Ectopic to Orthotopic Tumor Grafting Sites: Evidence for a Critical Role of the Host Tissue Microenvironment for the Actual Expression of the Malignant Phenotype
5. The Effects of the Organ Microenvironment on Metastatic-Cell Gene Signatures
6. Techniques for surgical orthotopic implantation of human tumors to immunodeficient mice
7. The first patient-derived orthotopic xenograft (PDOX) mouse models of cancer: Cancer of the colon, pancreas, lung, breast, ovary, and mesothelioma
8. Patient-derived xenograft models of prostate cancer
9. Patient-Derived Mouse Models of Sarcoma
10. Cervical cancer patient-derived orthotopic xenograft (PDOX) models
11. The use of pediatric patient-derived xenografts for identifying novel agents and combinations
12. Development of Orthotopic and Spontaneous Metastatic Human Tumor Xenograft Models for Experimental Therapeutics
13. Use of patient-derived orthotopic xenografts (PDOX) to evaluate transformative cancer therapeutics
14. Fluorescent protein-expressing transgenic nude mice as hosts for patient tumors
15. Fluorescence imaging of tumors in human patient-derived orthotopic xenograft (PDOX) mouse models: The iPDOX model
16. The use of patient-derived orthotopic xenograft (PDOX) models to develop curative fluorescence-guided surgery of cancer
17. Molecular characteristics of patient-derived tumor xenografts: genomic similarity to patient tumors and relevance for biomarker discovery
18. Complementarity of patient-derived orthotopic xenografts (PDOX) models and molecular profiling for optimal therapy
19. 3D Cell Culture Models
20. Why patient derived mouse models need to be orthotopic
21. Foreward: The future of patient-derived models of cancer
